A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children
Clinical trial NCT02637687 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02637687
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-16
- Primary completion
- 2024-07-20
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.